Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
4.200
+0.100 (2.44%)
At close: Aug 6, 2026, 4:00 PM EDT
4.190
-0.010 (-0.24%)
After-hours: Aug 6, 2026, 7:46 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $438.41 million as of August 6, 2026. Its market cap has increased by 36.96% in one year.
Market Cap
438.41M
Enterprise Value
287.10M
1-Year Change
36.96%
Ranking
Category
Stock Price
$4.20
ChartMarket Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $438.41M, an increase of 286.67%. That is a compound annual growth rate of 24.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 438.41M | 34.44% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cabaletta Bio | 454.92M |
| Prelude Therapeutics | 448.28M |
| Prothena Corporation | 445.00M |
| Ocugen | 443.46M |
| Ovid Therapeutics | 434.87M |
| Editas Medicine | 431.23M |
| Benitec Biopharma | 430.12M |
| Sutro Biopharma | 425.36M |